Plasfer announces that a patent has been granted by European Patent Office, strengthening the company’s intellectual property position in platelets-based therapeutics technologies.

EP 2951292 B1
Platelets transfected by exogenous genetic material and platelet microparticles obtained by said transfected platelets, method for the preparation and uses thereof for therapeutic applications.

(Full Press Release)